Trials / Terminated
TerminatedNCT03754244
A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetic characteristics of TQ-B3456 in the human body, recommend a reasonable regimen for subsequent research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQB3456 | Observe the safety and pk when the subjects take TQB3456 p.o. qd |
Timeline
- Start date
- 2020-09-24
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
- First posted
- 2018-11-27
- Last updated
- 2022-04-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03754244. Inclusion in this directory is not an endorsement.